ISBUC Innovation Day 2026

ISBUC Innovation Day 2026 is a one-day event dedicated to exploring how structural biology is driving innovation in medicine, biotechnology, and drug discovery. Hosted at the University of Copenhagen, the event brings together scientists, entrepreneurs, and industry leaders to discuss emerging technologies, translational research, and new opportunities at the interface of academia and biotech.

The program features keynote presentations and sessions on health and medicine, structure-based drug design, the path from research to innovation, and emerging technologies shaping the future of the field. Speakers include leading experts from universities, biotech startups, and innovation organizations across Scandinavia and beyond.

In addition to the talks, the event will include a poster session, providing an opportunity for researchers to present their work and engage with colleagues. The day will conclude with networking over drinks, encouraging new collaborations and conversations across disciplines.

Click to register here

 

Session 1: Focus on health and medicine

  • João Ribas (Partner, Novo Holdings): Building Orbis Medicines from Day 0
  • Henriette Autzen (Co-Founder of Polyceutix and RadPoly / Associate Professor, Department of Biomedical Sciences, University of Copenhagen): TBC
  • Morten Lindow (Head of the Center for Pharmaceutical Data Science Education, University of Copenhagen): Some of what I learned about RNA, Data and Drugs

Session 2: New frontiers in structure-based drug design 

  • Chris Norn (Co-Founder and CEO, Skape Bio): De novo design of miniprotein agonists and antagonists targeting G protein-coupled receptors
  • Eva Maria Rebrova (Co-Founder of Yngvi Bio / Researcher at Lund University): Regulating immune pore assembly on and off the membrane 
  • Amelie Stein (Partner KIDnEx2 / Associate Professor, Department of Biology, University of Copenhagen): TBC
  • Dek Woolfson (Head of the Center for Protein Design, University of Copenhagen): TBC

Session 3: Path to Innovation

  • KU Lighthouse
  • Iben Nikolajsen (BioInnovation Institute):TBC
  • Christoffer Merrild (Nucleate): TBC
  • Lundbeck Foundation 
  • Innovation Fund Denmark 
  • ODIN

Session 4: Technologies on the edge

  • Ebba Carbonnier (Chief Executive Officer of QuNorth): TBC
  • Tone Bengtsen (Management Consultant, ADC Consulting): TBC
  • Nikolaj Thomas Zinner (Co-Founder, Kvantify / Professor at Aarhus University)